Evoq Remedies Limited (BOM:543500)

Evoq Remedies Statistics

Total Valuation

Evoq Remedies has a market cap or net worth of INR 74.20 million. The enterprise value is 71.12 million.

Market Cap	74.20M
Enterprise Value	71.12M

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Evoq Remedies has 24.90 million shares outstanding. The number of shares has increased by 30.91% in one year.

Current Share Class	24.90M
Shares Outstanding	24.90M
Shares Change (YoY)	+30.91%
Shares Change (QoQ)	+9.44%
Owned by Insiders (%)	48.21%
Owned by Institutions (%)	n/a
Float	12.53M

Valuation Ratios

The trailing PE ratio is 4.38.

PE Ratio	4.38
Forward PE	n/a
PS Ratio	0.18
PB Ratio	0.17
P/TBV Ratio	0.17
P/FCF Ratio	2.61
P/OCF Ratio	2.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.74, with an EV/FCF ratio of 2.50.

EV / Earnings	4.03
EV / Sales	0.17
EV / EBITDA	3.74
EV / EBIT	3.88
EV / FCF	2.50

Financial Position

The company has a current ratio of 6.82

Current Ratio	6.82
Quick Ratio	0.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 4.04% and return on invested capital (ROIC) is 3.99%.

Return on Equity (ROE)	4.04%
Return on Assets (ROA)	2.29%
Return on Invested Capital (ROIC)	3.99%
Return on Capital Employed (ROCE)	4.11%
Weighted Average Cost of Capital (WACC)	10.41%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.82
Inventory Turnover	20.66

Taxes

In the past 12 months, Evoq Remedies has paid 645,000 in taxes.

Income Tax	645,000
Effective Tax Rate	3.52%

Stock Price Statistics

The stock price has decreased by -59.72% in the last 52 weeks. The beta is 1.12, so Evoq Remedies's price volatility has been higher than the market average.

Beta (5Y)	1.12
52-Week Price Change	-59.72%
50-Day Moving Average	3.27
200-Day Moving Average	3.81
Relative Strength Index (RSI)	44.09
Average Volume (20 Days)	47,400

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Evoq Remedies had revenue of INR 407.29 million and earned 17.67 million in profits. Earnings per share was 0.68.

Revenue	407.29M
Gross Profit	40.50M
Operating Income	18.31M
Pretax Income	18.31M
Net Income	17.67M
EBITDA	19.03M
EBIT	18.31M
Earnings Per Share (EPS)	0.68

Balance Sheet

The company has 3.08 million in cash and n/a in debt, with a net cash position of 3.08 million or 0.12 per share.

Cash & Cash Equivalents	3.08M
Total Debt	n/a
Net Cash	3.08M
Net Cash Per Share	0.12
Equity (Book Value)	445.90M
Book Value Per Share	16.42
Working Capital	443.94M

Cash Flow

In the last 12 months, operating cash flow was 31.04 million and capital expenditures -2.58 million, giving a free cash flow of 28.46 million.

Operating Cash Flow	31.04M
Capital Expenditures	-2.58M
Free Cash Flow	28.46M
FCF Per Share	1.14

Margins

Gross margin is 9.94%, with operating and profit margins of 4.50% and 4.34%.

Gross Margin	9.94%
Operating Margin	4.50%
Pretax Margin	4.50%
Profit Margin	4.34%
EBITDA Margin	4.67%
EBIT Margin	4.50%
FCF Margin	6.99%

Dividends & Yields

Evoq Remedies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.91%
Shareholder Yield	-30.91%
Earnings Yield	23.81%
FCF Yield	38.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6